Skip to content

Continuous dynamic intrathoracic pressure monitoring to guide invasive mechanical ventilation strategies: a prospective randomized controlled study

Continuous dynamic intrathoracic pressure monitoring to guide invasive mechanical ventilation strategies: a prospective randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064730
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory failure

Interventions

Intervention group:Continuous dynamic invasive intrathoracic pressure monitoring
Control group:Traditional mechanical ventilation strategy

Sponsors

Shanghai fourth people's Hospital affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old, regardless of gender; 2. Meets the diagnostic criteria for ARF (ARDS), and the diagnosis of ARF does not exceed 48 hours after enrollment: 1) Within one week after the known cause, or after new or existing respiratory symptoms worsen; 2) Reduced transparency of both lungs, which cannot be fully explained by pleural effusion, atelectasis, or nodules; 3) Respiratory failure that cannot be explained by heart failure or excessive fluid load, if there are no risk factors, requires objective evaluation (such as cardiac ultrasound examination) to exclude pulmonary edema caused by increased hydrostatic pressure; 4) When PEEP/CPP>=5 cmH2O, PaO2/FiO2<=300mm Hg. 3. Conduct invasive mechanical ventilation and have bedside respiratory and circulatory monitoring facilities; 4. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Recent major chest surgeries; 2. Existence of bronchopleural fistula; 3. Existence of solid organ transplantation; 4. Pregnancy; 5. There is severe coagulation dysfunction and severe decrease in platelets.

Design outcomes

Primary

MeasureTime frame
PaO2/FiO2 Ratio on 72h;

Secondary

MeasureTime frame
28-day all-cause mortality;Mechanical ventilation support time;Other organ function support time;Incidence of nosocomial infection;Time of staying in ICU;Complications of mechanical ventilation (pressure sores, pneumothorax, etc.);

Countries

China

Contacts

Public ContactJian Song

Shanghai fourth people's Hospital affiliated to Tongji University

342318432@qq.com+86 18652232336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026